PentaBind
Developer of precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect an...
Valuation
$8.5M
Latest known
Share Price
N/A
Total Raised
$2.5M
Last Round
N/A